What additional immunomodulation would you consider in a patient with severe NXP-2+ JDM who has already received cyclophosphamide and rituximab but has persistent gastrointestinal vasculopathy?
1 Answer
Mednet Member
Rheumatology · University of Chicago
Answered on
I'd try a JAKi.
Join for free or sign in to see the full answer